December 2024 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2024-12-31, 20 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of December 2024

100

Ranked drops

-78.93%

Largest, CRVO

88.9%

Below baseline, day +5

5.8%

Median deeper below baseline, day +5

Filter and sort

100 ranked drops in December 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	CRVO	-78.93%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies 12/10/2024 07:00 ET premarket	Day +1 -80.98% 2024-12-11 Day +5 -81.07% 2024-12-17 Best recovery within 5 -80.98% 2024-12-11 Five sessions later the drop was 2.7% bigger, at -81.07%. Month end -77.17% on 2024-12-31
Close before and after $10.25 to $2.16 split-adjusted Session open, high, low $2.53, $2.80, $2.11 Opening gap -75.32% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 8,312,419 shares, $17,954,825 Relative volume 75.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
2	AILE	-78.53%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	iLearningEngines Voluntarily Initiates Chapter 11 Proceedings 12/23/2024 08:00 ET premarket	Day +1 -76.72% 2024-12-24 Day +5 -52.54% 2024-12-31 Best recovery within 5 -20.11% 2024-12-30 33.1% of the drop was recovered five sessions later. Month end -52.54% on 2024-12-31
Close before and after $0.8850 to $0.1900 as traded Session open, high, low $0.4000, $0.4100, $0.1900 Opening gap -54.80% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 29,710,385 shares, $5,644,973 Relative volume 90.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
3	RLMD	-77.26%	2024-12-04 against the close of 2024-12-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Relmada Therapeutics Reports That Data Monitoring Committee (DMC) Assessment Indicates That the Phase 3 Reliance II Trial is Futile at its Interim Analysis and is Unlikely to Meet the Primary Efficacy Endpoint with Statistical Significance 12/04/2024 07:30 ET premarket	Day +1 -83.75% 2024-12-05 Day +5 -84.93% 2024-12-11 Best recovery within 5 -82.64% 2024-12-09 Five sessions later the drop was 9.9% bigger, at -84.93%. Month end -81.23% on 2024-12-31
Close before and after $2.77 to $0.6300 split-adjusted Session open, high, low $0.6950, $0.7270, $0.6200 Opening gap -74.91% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 17,988,412 shares, $11,332,700 Relative volume 145.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	BIOA	-76.85%	2024-12-09 against the close of 2024-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results (terminated)	BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity 12/06/2024 16:35 ET after hours	Day +1 -77.75% 2024-12-10 Day +5 -79.39% 2024-12-16 Best recovery within 5 -76.11% 2024-12-11 Five sessions later the drop was 3.3% bigger, at -79.39%. Month end -71.18% on 2024-12-31
Close before and after $20.09 to $4.65 split-adjusted Session open, high, low $5.65, $5.75, $4.50 Opening gap -71.88% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 10,202,061 shares, $47,439,584 Relative volume 46.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
5	CLRB under $25M today release reads positive	-76.16%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results Release reads positive, stock fell 76.16%	Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring 12/10/2024 17:00 ET after hours	Day +1 -79.37% 2024-12-12 Day +5 -80.55% 2024-12-18 Best recovery within 5 -79.37% 2024-12-12 Five sessions later the drop was 5.8% bigger, at -80.55%. Month end -76.64% on 2024-12-31
Close before and after $38.40 to $9.16 split-adjusted Session open, high, low $12.87, $13.65, $8.52 Opening gap -66.48% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 1,273,599 shares, $11,661,072 Relative volume 109.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	QTTB	-75.62%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program 12/10/2024 16:05 ET after hours	Day +1 -82.59% 2024-12-12 Day +5 -87.18% 2024-12-18 Best recovery within 5 -82.59% 2024-12-12 Five sessions later the drop was 15.3% bigger, at -87.18%. Month end -85.91% on 2024-12-31
Close before and after $24.41 to $5.95 split-adjusted Session open, high, low $8.00, $8.48, $5.80 Opening gap -67.23% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 3,436,983 shares, $20,450,049 Relative volume 29.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	SPGC under $25M today	-73.36%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Sacks Parente Golf, Inc. Announces Pricing of Upsized $8.4 Million Underwritten Public Offering 12/12/2024 08:48 ET premarket	Day +1 -77.93% 2024-12-13 Day +5 -76.16% 2024-12-19 Best recovery within 5 -76.16% 2024-12-19 Five sessions later the drop was 3.8% bigger, at -76.16%. Month end -70.01% on 2024-12-31
Close before and after $42.00 to $11.19 as traded Session open, high, low $9.85, $12.54, $8.40 Opening gap -76.55% Close inside the session range 0.67 of the range, where 1.00 is the high Session volume 991,663 shares, $11,093,734 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	KROS	-73.15%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial 12/12/2024 06:00 ET premarket	Day +1 -72.57% 2024-12-13 Day +5 -75.35% 2024-12-19 Best recovery within 5 -71.71% 2024-12-16 Five sessions later the drop was 3.0% bigger, at -75.35%. Month end -76.94% on 2024-12-31
Close before and after $68.65 to $18.43 split-adjusted Session open, high, low $18.71, $19.34, $15.67 Opening gap -72.75% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 14,645,678 shares, $269,919,846 Relative volume 31.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
9	CYN under $25M today Also on the opposite board this month on both boards	-70.88%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Cyngn Announces Pricing of $20.0 Million Follow On Offering Priced At-the-Market 12/20/2024 09:00 ET premarket	Day +1 -56.52% 2024-12-23 Day +5 -49.67% 2024-12-30 Best recovery within 5 -49.67% 2024-12-30 29.9% of the drop was recovered five sessions later. Month end -47.26% on 2024-12-31
Close before and after $241.50 to $70.34 split-adjusted Session open, high, low $55.50, $73.35, $52.71 Opening gap -77.02% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 186,446 shares, $13,113,679 Relative volume 230.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	MYNA under $25M today	-64.60%	2024-12-06 against the close of 2024-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Mynaric Enters into Negotiation for Further Funding with Existing Lender Subject to Financial Reorganization Under StaRUG, and Postpones Upcoming AGM 12/06/2024 08:30 ET premarket	Day +1 -68.14% 2024-12-09 Day +5 -73.75% 2024-12-13 Best recovery within 5 -67.55% 2024-12-10 Five sessions later the drop was 14.2% bigger, at -73.75%. Month end -47.15% on 2024-12-31
Close before and after $1.41 to $0.4992 as traded Session open, high, low $0.8500, $0.8801, $0.4001 Opening gap -39.72% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 3,618,636 shares, $1,806,423 Relative volume 145.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	LITM More than one ranked move this month 2+ ranked moves	-63.14%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Snow Lake Energy Announces Pricing of Public Offering 12/19/2024 06:30 ET premarket Snow Lake Energy Announces Proposed Public Offering 12/18/2024	Day +1 -55.19% 2024-12-20 Day +5 +95.24% 2024-12-27 Best recovery within 5 +95.24% 2024-12-27 It recovered the whole drop and closed 95.24% above the pre-news price. Month end +17.14% on 2024-12-31
Close before and after $10.65 to $3.93 as traded Session open, high, low $5.59, $5.81, $3.58 Opening gap -47.53% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 5,557,221 shares, $21,824,874 Relative volume 41.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	SGMO	-56.41%	2024-12-31 against the close of 2024-12-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program Following Pfizer’s Decision to Cease Development of Giroctocogene Fitelparvovec 12/30/2024 16:15 ET after hours	Day +1 -51.71% 2025-01-02 Day +5 -48.08% 2025-01-08 Best recovery within 5 -41.45% 2025-01-07 14.8% of the drop was recovered five sessions later. Month end -56.41% on 2024-12-31 same session This month ended before the fifth session after the move.
Close before and after $2.34 to $1.02 as traded Session open, high, low $1.07, $1.26, $0.9100 Opening gap -54.27% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 44,556,131 shares, $45,447,254 Relative volume 9.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	RPTX	-55.42%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial 12/12/2024 16:20 ET after hours	Day +1 -59.70% 2024-12-16 Day +5 -66.75% 2024-12-20 Best recovery within 5 -59.70% 2024-12-16 Five sessions later the drop was 20.4% bigger, at -66.75%. Month end -67.00% on 2024-12-31
Close before and after $3.97 to $1.77 as traded Session open, high, low $2.31, $2.40, $1.66 Opening gap -41.81% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 4,696,286 shares, $8,312,426 Relative volume 33.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
14	TNYA	-51.04%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 12/16/2024 16:30 ET after hours Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy 12/17/2024	Day +1 -57.29% 2024-12-18 Day +5 -42.36% 2024-12-24 Best recovery within 5 -42.01% 2024-12-20 17.0% of the drop was recovered five sessions later. Month end -50.35% on 2024-12-31
Close before and after $2.88 to $1.41 split-adjusted Session open, high, low $2.00, $2.00, $0.9867 Opening gap -30.56% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 42,457,673 shares, $59,865,319 Relative volume 9.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	DNMR under $25M today More than one ranked move this month 2+ ranked moves	-49.15%	2024-12-31 against the close of 2024-12-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace 12/31/2024 08:00 ET premarket	Day +1 -46.73% 2025-01-02 Day +5 -58.60% 2025-01-08 Best recovery within 5 -46.73% 2025-01-02 Five sessions later the drop was 19.2% bigger, at -58.60%. Month end -49.15% on 2024-12-31 same session This month ended before the fifth session after the move.
Close before and after $4.13 to $2.10 as traded Session open, high, low $3.87, $3.89, $1.81 Opening gap -6.30% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 461,857 shares, $969,900 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	GALT	-48.00%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH 12/20/2024 08:00 ET premarket	Day +1 -55.49% 2024-12-23 Day +5 -45.00% 2024-12-30 Best recovery within 5 -42.50% 2024-12-27 6.3% of the drop was recovered five sessions later. Month end -35.50% on 2024-12-31
Close before and after $2.00 to $1.04 split-adjusted Session open, high, low $1.18, $1.50, $0.7260 Opening gap -41.00% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 9,268,164 shares, $9,638,891 Relative volume 15.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	OPTT	-47.14%	2024-12-03 against the close of 2024-12-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Ocean Power Technologies Pre-Releases Preliminary Financial Results for Second Quarter Fiscal 2025 12/02/2024 16:15 ET after hours	Day +1 -41.21% 2024-12-04 Day +5 -57.66% 2024-12-10 Best recovery within 5 -41.21% 2024-12-04 Five sessions later the drop was 22.3% bigger, at -57.66%. Month end +45.71% on 2024-12-31
Close before and after $0.7000 to $0.3700 split-adjusted Session open, high, low $0.3600, $0.4200, $0.2950 Opening gap -48.57% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 103,055,183 shares, $38,130,418 Relative volume 42.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	FNGR under $25M today	-46.50%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	FingerMotion Announces $5.0 Million Registered Direct Offering 12/20/2024 07:30 ET premarket	Day +1 -44.00% 2024-12-23 Day +5 -41.00% 2024-12-30 Best recovery within 5 -36.50% 2024-12-26 11.8% of the drop was recovered five sessions later. Month end -40.00% on 2024-12-31
Close before and after $2.00 to $1.07 split-adjusted Session open, high, low $1.50, $1.55, $1.03 Opening gap -25.00% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 4,475,047 shares, $4,788,300 Relative volume 26.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	GTI under $25M today	-44.51%	2024-12-26 against the close of 2024-12-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Malaysia Deputy Minister of Plantation and Commodities YB Datuk Chan Foong Hin Visits Graphjet Technology’s First-of-its-Kind Green Graphite Facility 12/26/2024 08:00 ET premarket	Day +1 +65.57% 2024-12-27 Day +5 +45.90% 2025-01-03 Best recovery within 5 +116.39% 2024-12-30 It recovered the whole drop and closed 45.90% above the pre-news price. Month end +47.54% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $36.60 to $20.31 as traded Session open, high, low $33.15, $35.82, $19.91 Opening gap -9.43% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 374,047 shares, $7,596,895 Relative volume 15.5x the median of the 20 sessions before the pre-news close Baseline gap 2 calendar days from the pre-news close to the measured session
20	BATL	-42.92%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition (terminated)	Battalion Oil Corporation Announces Termination of Merger Agreement with Fury Resources, Inc. and Provides Operations Update 12/20/2024 09:00 ET premarket	Day +1 -34.70% 2024-12-23 Day +5 -22.79% 2024-12-30 Best recovery within 5 -14.58% 2024-12-27 46.9% of the drop was recovered five sessions later. Month end -29.36% on 2024-12-31
Close before and after $2.44 to $1.39 split-adjusted Session open, high, low $2.34, $2.34, $1.31 Opening gap -3.90% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 1,635,017 shares, $2,272,674 Relative volume 51.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
21	KZIA release reads positive	-42.90%	2024-12-31 against the close of 2024-12-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory Release reads positive, stock fell 42.90%	Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA 12/31/2024 08:00 ET premarket	Day +1 -43.71% 2025-01-02 Day +5 -45.48% 2025-01-08 Best recovery within 5 -41.94% 2025-01-03 Five sessions later the drop was 6.0% bigger, at -45.48%. Month end -42.90% on 2024-12-31 same session This month ended before the fifth session after the move.
Close before and after $15.50 to $8.85 split-adjusted Session open, high, low $14.25, $14.65, $8.75 Opening gap -8.06% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 141,798 shares, $1,254,912 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	BCAB under $25M today	-41.82%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points 12/20/2024 09:00 ET premarket	Day +1 -48.66% 2024-12-23 Day +5 -50.42% 2024-12-30 Best recovery within 5 -46.22% 2024-12-26 Five sessions later the drop was 20.6% bigger, at -50.42%. Month end -50.32% on 2024-12-31
Close before and after $59.50 to $34.62 split-adjusted Session open, high, low $54.00, $54.00, $33.50 Opening gap -9.24% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 124,951 shares, $4,325,179 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
23	LITM More than one ranked move this month 2+ ranked moves	-41.56%	2024-12-30 against the close of 2024-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Snow Lake Energy Announces Pricing of US$15 Million Public Offering 12/29/2024 21:48 ET after hours	Day +1 -40.00% 2024-12-31 Day +5 -42.50% 2025-01-07 Best recovery within 5 -38.75% 2025-01-06 Five sessions later the drop was 2.3% bigger, at -42.50%. Month end -40.00% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $20.80 to $12.16 as traded Session open, high, low $11.88, $17.94, $11.70 Opening gap -42.87% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 5,329,149 shares, $64,775,806 Relative volume 19.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
24	MRM under $25M today release reads positive	-41.43%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Release reads positive, stock fell 41.43%	MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering 12/09/2024 20:14 ET after hours	Day +1 -43.57% 2024-12-11 Day +5 -62.14% 2024-12-17 Best recovery within 5 -43.57% 2024-12-11 Five sessions later the drop was 50.0% bigger, at -62.14%. Month end -63.21% on 2024-12-31
Close before and after $2.80 to $1.64 split-adjusted Session open, high, low $1.73, $1.73, $1.30 Opening gap -38.21% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 1,798,422 shares, $2,949,412 Relative volume 452.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	AKTS	-40.03%	2024-12-16 against the close of 2024-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process 12/16/2024 01:19 ET premarket	Day +1 -45.45% 2024-12-17 Day +5 no data Best recovery within 5 so far -45.45% 2024-12-17 Month-end is not shown: no closing price is available for 2024-12-31.
Close before and after $0.0682 to $0.0409 split-adjusted Session open, high, low $0.0450, $0.0550, $0.0400 Opening gap -34.02% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 53,758,437 shares, $2,198,720 Relative volume 4.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
26	BCTX	-39.89%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering 12/11/2024 23:54 ET after hours BriaCell Therapeutics Announces Proposed Public Offering 12/11/2024	Day +1 -40.00% 2024-12-13 Day +5 -46.81% 2024-12-19 Best recovery within 5 -40.00% 2024-12-13 Five sessions later the drop was 17.3% bigger, at -46.81%. Month end -48.64% on 2024-12-31
Close before and after $165.00 to $99.18 split-adjusted Session open, high, low $102.27, $106.50, $89.25 Opening gap -38.02% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 52,879 shares, $5,244,539 Relative volume 7.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	RVPH under $25M today	-39.13%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Reviva Announces Proposed Public Offering 12/16/2024 17:18 ET after hours Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants 12/16/2024	Day +1 -37.61% 2024-12-18 Day +5 -22.61% 2024-12-24 Best recovery within 5 -22.61% 2024-12-24 42.2% of the drop was recovered five sessions later. Month end -21.30% on 2024-12-31
Close before and after $46.00 to $28.00 split-adjusted Session open, high, low $28.80, $31.80, $25.00 Opening gap -37.39% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 907,831 shares, $25,419,268 Relative volume 35.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
28	BDMD release reads positive	-38.95%	2024-12-30 against the close of 2024-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 38.95%	Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum 12/30/2024 08:46 ET premarket	Day +1 +341.86% 2024-12-31 Day +5 +337.21% 2025-01-07 Best recovery within 5 +341.86% 2024-12-31 It recovered the whole drop and closed 337.21% above the pre-news price. Month end +341.86% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $1.72 to $1.05 split-adjusted Session open, high, low $1.80, $1.80, $1.05 Opening gap +4.65% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 153,541 shares, $161,218 Relative volume 5.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
29	HWH under $25M today release reads positive	-38.81%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership Release reads positive, stock fell 38.81%	HWH International Inc. and Guangzhou Inbot Technology Ltd Announce Strategic Partnership to Drive Global Robotics Expansion 12/10/2024 09:20 ET premarket	Day +1 -37.62% 2024-12-11 Day +5 -49.60% 2024-12-17 Best recovery within 5 -32.97% 2024-12-13 Five sessions later the drop was 27.8% bigger, at -49.60%. Month end -36.15% on 2024-12-31
Close before and after $5.05 to $3.09 split-adjusted Session open, high, low $5.95, $7.20, $3.08 Opening gap +17.82% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 2,072,410 shares, $6,403,747 Relative volume 761.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	AMBO under $25M today	-38.42%	2024-12-31 against the close of 2024-12-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Ambow Education Announces Second Quarter and First Half of 2024 Financial Results 12/30/2024 16:01 ET after hours	Day +1 -10.56% 2025-01-02 Day +5 -37.24% 2025-01-08 Best recovery within 5 -10.56% 2025-01-02 3.1% of the drop was recovered five sessions later. Month end -38.42% on 2024-12-31 same session This month ended before the fifth session after the move.
Close before and after $3.41 to $2.10 split-adjusted Session open, high, low $3.45, $3.45, $1.86 Opening gap +1.17% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 200,878 shares, $421,844 Relative volume 9.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	INO	-38.30%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	INOVIO Announces Proposed Public Offering 12/12/2024 16:01 ET after hours INOVIO Announces Pricing of $30 Million Public Offering 12/13/2024	Day +1 -42.82% 2024-12-16 Day +5 -51.06% 2024-12-20 Best recovery within 5 -42.82% 2024-12-16 Five sessions later the drop was 33.3% bigger, at -51.06%. Month end -51.33% on 2024-12-31
Close before and after $3.76 to $2.32 split-adjusted Session open, high, low $2.52, $2.54, $2.14 Opening gap -32.98% Close inside the session range 0.45 of the range, where 1.00 is the high Session volume 9,858,780 shares, $22,872,370 Relative volume 19.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	COCP under $25M today	-37.85%	2024-12-31 against the close of 2024-12-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344 12/31/2024 08:00 ET premarket	Day +1 -28.62% 2025-01-02 Day +5 -25.94% 2025-01-08 Best recovery within 5 -25.94% 2025-01-08 31.5% of the drop was recovered five sessions later. Month end -37.85% on 2024-12-31 same session This month ended before the fifth session after the move.
Close before and after $3.25 to $2.02 split-adjusted Session open, high, low $2.20, $2.29, $1.91 Opening gap -32.31% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 530,183 shares, $1,070,970 Relative volume 20.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	PSQH Also on the opposite board this month on both boards	-37.75%	2024-12-04 against the close of 2024-12-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	PublicSquare Announces $36.2 Million Registered Direct Offering of Common Stock 12/04/2024 08:00 ET premarket	Day +1 -43.64% 2024-12-05 Day +5 -46.26% 2024-12-11 Best recovery within 5 -41.02% 2024-12-09 Five sessions later the drop was 22.5% bigger, at -46.26%. Month end -40.50% on 2024-12-31
Close before and after $114.45 to $71.25 split-adjusted Session open, high, low $77.70, $85.35, $68.25 Opening gap -32.11% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 1,876,264 shares, $133,683,810 Relative volume 133.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	TRAW under $25M today Also on the opposite board this month on both boards	-37.26%	2024-12-30 against the close of 2024-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval 12/30/2024 08:00 ET premarket	Day +1 -33.83% 2024-12-31 Day +5 -32.71% 2025-01-07 Best recovery within 5 -32.41% 2025-01-06 12.2% of the drop was recovered five sessions later. Month end -33.83% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $13.42 to $8.42 split-adjusted Session open, high, low $8.00, $8.90, $7.40 Opening gap -40.39% Close inside the session range 0.68 of the range, where 1.00 is the high Session volume 1,202,621 shares, $10,126,069 Relative volume 153.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
35	TNXP More than one ranked move this month 2+ ranked moves	-37.00%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia 12/17/2024 08:00 ET premarket	Day +1 -31.17% 2024-12-18 Day +5 -27.30% 2024-12-24 Best recovery within 5 +15.40% 2024-12-20 26.2% of the drop was recovered five sessions later. Month end -37.77% on 2024-12-31
Close before and after $53.00 to $33.39 split-adjusted Session open, high, low $127.00, $130.00, $32.00 Opening gap +139.62% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 10,183,233 shares, $340,018,150 Relative volume 34.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	CRVS	-36.40%	2024-12-18 against the close of 2024-12-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Corvus Pharmaceuticals to Announce Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024 12/17/2024 16:01 ET after hours Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis 12/18/2024	Day +1 -31.12% 2024-12-19 Day +5 -28.42% 2024-12-26 Best recovery within 5 -28.42% 2024-12-26 21.9% of the drop was recovered five sessions later. Month end -27.60% on 2024-12-31
Close before and after $7.39 to $4.70 split-adjusted Session open, high, low $5.00, $5.20, $3.77 Opening gap -32.34% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 14,074,650 shares, $66,150,855 Relative volume 20.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	ADCT Also on the opposite board this month release reads positive on both boards	-36.21%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results Release reads positive, stock fell 36.21%	ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma 12/11/2024 07:30 ET premarket	Day +1 -43.10% 2024-12-12 Day +5 -45.11% 2024-12-18 Best recovery within 5 -38.79% 2024-12-17 Five sessions later the drop was 24.6% bigger, at -45.11%. Month end -42.82% on 2024-12-31
Close before and after $3.48 to $2.22 split-adjusted Session open, high, low $3.37, $3.47, $2.06 Opening gap -3.16% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 5,627,287 shares, $12,492,577 Relative volume 11.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	FLGC under $25M today	-34.34%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Flora Growth Corp. Announces Pricing of $3.6 Million Registered Direct Offering 12/13/2024 09:00 ET premarket	Day +1 -38.38% 2024-12-16 Day +5 -46.97% 2024-12-20 Best recovery within 5 -38.38% 2024-12-16 Five sessions later the drop was 36.8% bigger, at -46.97%. Month end -47.98% on 2024-12-31
Close before and after $77.22 to $50.70 as traded Session open, high, low $59.28, $61.23, $47.19 Opening gap -23.23% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 106,146 shares, $5,381,602 Relative volume 13.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	TNXP More than one ranked move this month 2+ ranked moves	-34.09%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia 12/23/2024 08:00 ET premarket	Day +1 -37.00% 2024-12-24 Day +5 -46.08% 2024-12-31 Best recovery within 5 -37.00% 2024-12-24 Five sessions later the drop was 35.2% bigger, at -46.08%. Month end -46.08% on 2024-12-31
Close before and after $61.16 to $40.31 split-adjusted Session open, high, low $49.90, $52.97, $39.60 Opening gap -18.41% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 1,953,598 shares, $78,749,535 Relative volume 6.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
40	IDAI under $25M today	-33.83%	2024-12-02 against the close of 2024-11-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Trust Stamp to Provide Strategic Update and Announces Annual General Meeting Details 12/02/2024 11:20 ET intraday	Day +1 -11.12% 2024-12-03 Day +5 -21.48% 2024-12-09 Best recovery within 5 -11.12% 2024-12-03 36.5% of the drop was recovered five sessions later. Month end +28.00% on 2024-12-31
Close before and after $10.35 to $6.85 split-adjusted Session open, high, low $9.00, $9.83, $6.63 Opening gap -13.00% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 859,190 shares, $5,884,592 Relative volume 7.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
41	STEC	-32.99%	2024-12-05 against the close of 2024-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Santech Holdings Limited Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement 12/05/2024 06:14 ET premarket	Day +1 -26.80% 2024-12-06 Day +5 -17.02% 2024-12-12 Best recovery within 5 -17.02% 2024-12-12 48.4% of the drop was recovered five sessions later. Month end +26.80% on 2024-12-31
Close before and after $0.9700 to $0.6500 as traded Session open, high, low $0.7000, $0.7300, $0.6100 Opening gap -27.84% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 4,733,655 shares, $3,076,876 Relative volume 137.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	BTCT More than one ranked move this month 2+ ranked moves	-32.95%	2024-12-06 against the close of 2024-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	BTC Digital Ltd. Announces Launch of Proposed Underwritten Public Offering 12/05/2024 20:05 ET after hours BTC Digital Ltd. Announces Pricing of $20.0 Million Underwritten Public Offering 12/06/2024	Day +1 -35.38% 2024-12-09 Day +5 -59.26% 2024-12-13 Best recovery within 5 -35.38% 2024-12-09 Five sessions later the drop was 79.8% bigger, at -59.26%. Month end -69.48% on 2024-12-31
Close before and after $15.66 to $10.50 split-adjusted Session open, high, low $11.00, $12.51, $10.42 Opening gap -29.76% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 3,309,460 shares, $34,749,330 Relative volume 2.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	ANAB	-32.83%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis 12/11/2024 08:30 ET premarket	Day +1 -34.95% 2024-12-12 Day +5 -33.56% 2024-12-18 Best recovery within 5 -27.89% 2024-12-16 Five sessions later the drop was 2.2% bigger, at -33.56%. Month end -42.66% on 2024-12-31
Close before and after $23.09 to $15.51 split-adjusted Session open, high, low $14.32, $16.93, $14.20 Opening gap -37.98% Close inside the session range 0.48 of the range, where 1.00 is the high Session volume 4,104,437 shares, $63,659,818 Relative volume 8.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	NEHC under $25M today	-32.59%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Up, Up and Away with Helium Stocks; The Critical Element Powering Tomorrow's Tech 12/10/2024 09:00 ET premarket	Day +1 -38.71% 2024-12-11 Day +5 -62.94% 2024-12-17 Best recovery within 5 -38.71% 2024-12-11 Five sessions later the drop was 93.1% bigger, at -62.94%. Month end -29.41% on 2024-12-31
Close before and after $8.50 to $5.73 as traded Session open, high, low $9.00, $9.00, $4.63 Opening gap +5.88% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 650,354 shares, $3,726,528 Baseline gap 1 calendar day from the pre-news close to the measured session
45	HUIZ under $25M today	-32.51%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Huize Holding Limited Reports Third Quarter 2024 Unaudited Financial Results 12/10/2024 04:00 ET premarket	Day +1 -48.84% 2024-12-11 Day +5 -54.79% 2024-12-17 Best recovery within 5 -45.21% 2024-12-12 Five sessions later the drop was 68.5% bigger, at -54.79%. Month end -46.70% on 2024-12-31
Close before and after $6.06 to $4.09 split-adjusted Session open, high, low $4.90, $5.24, $3.99 Opening gap -19.14% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 431,328 shares, $1,764,132 Relative volume 121.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	VIRX under $25M today	-32.49%	2024-12-27 against the close of 2024-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives 12/26/2024 16:30 ET after hours	Day +1 -32.49% 2024-12-30 Day +5 -10.25% 2025-01-06 Best recovery within 5 -5.91% 2025-01-03 68.5% of the drop was recovered five sessions later. Month end -32.11% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $0.2370 to $0.1600 as traded Session open, high, low $0.2000, $0.2125, $0.1460 Opening gap -15.61% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 9,473,334 shares, $1,515,733 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	AMLI	-32.34%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	American Lithium Announces Intention to Voluntarily Delist Its Common Shares From Nasdaq Capital Market 12/10/2024 17:38 ET after hours	Day +1 -33.29% 2024-12-12 Day +5 -44.00% 2024-12-18 Best recovery within 5 -33.29% 2024-12-12 Five sessions later the drop was 36.1% bigger, at -44.00%. Month-end is not shown: no closing price is available for 2024-12-31.
Close before and after $0.6252 to $0.4230 as traded Session open, high, low $0.4800, $0.4810, $0.4000 Opening gap -23.22% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 6,383,193 shares, $2,700,091 Relative volume 16.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	SRM Also on the opposite board this month release reads positive on both boards	-32.33%	2024-12-05 against the close of 2024-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Release reads positive, stock fell 32.33%	SRM Entertainment, Inc. Announces Pricing of $1.7 Million Registered Direct Offering 12/05/2024 08:30 ET premarket	Day +1 -37.44% 2024-12-06 Day +5 -36.21% 2024-12-12 Best recovery within 5 -31.90% 2024-12-10 Five sessions later the drop was 12.0% bigger, at -36.21%. Month end -45.78% on 2024-12-31
Close before and after $1.16 to $0.7850 as traded Session open, high, low $0.8862, $0.8862, $0.7412 Opening gap -23.60% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 7,065,475 shares, $5,546,398 Relative volume 56.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	CVM	-32.26%	2024-12-30 against the close of 2024-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	CEL-SCI Announces Proposed Public Offering of Common Stock 12/27/2024 17:05 ET after hours CEL-SCI Announces Pricing of $5 Million Public Offering 12/29/2024	Day +1 -33.36% 2024-12-31 Day +5 -33.69% 2025-01-07 Best recovery within 5 -28.18% 2025-01-03 Five sessions later the drop was 4.4% bigger, at -33.69%. Month end -33.36% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $18.00 to $12.20 split-adjusted Session open, high, low $12.60, $13.07, $11.10 Opening gap -30.01% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 349,317 shares, $4,259,921 Relative volume 17.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
50	IBRX	-32.11%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	ImmunityBio, Inc. Announces Proposed Public Offering of Common Stock 12/10/2024 16:24 ET after hours ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock 12/11/2024	Day +1 -34.48% 2024-12-12 Day +5 -42.89% 2024-12-18 Best recovery within 5 -34.05% 2024-12-16 Five sessions later the drop was 33.6% bigger, at -42.89%. Month end -44.83% on 2024-12-31
Close before and after $4.64 to $3.15 split-adjusted Session open, high, low $3.28, $3.45, $3.06 Opening gap -29.31% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 28,653,842 shares, $90,259,602 Relative volume 7.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	RENB release reads positive	-31.71%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 31.71%	RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program 12/23/2024 09:00 ET premarket	Day +1 -37.20% 2024-12-24 Day +5 -49.05% 2024-12-31 Best recovery within 5 -37.20% 2024-12-24 Five sessions later the drop was 54.7% bigger, at -49.05%. Month end -49.05% on 2024-12-31
Close before and after $1.64 to $1.12 as traded Session open, high, low $1.64, $1.65, $1.10 Opening gap 0.00% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 1,277,124 shares, $1,430,379 Relative volume 1.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
52	LOVE	-31.69%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	The Lovesac Company Reports Third Quarter Fiscal 2025 Financial Results 12/12/2024 07:00 ET premarket	Day +1 -30.10% 2024-12-13 Day +5 -37.85% 2024-12-19 Best recovery within 5 -28.48% 2024-12-16 Five sessions later the drop was 19.4% bigger, at -37.85%. Month end -37.21% on 2024-12-31
Close before and after $37.68 to $25.74 split-adjusted Session open, high, low $28.19, $30.47, $25.53 Opening gap -25.19% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 2,586,978 shares, $66,588,814 Relative volume 10.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	BCYC	-31.33%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification 12/12/2024 18:30 ET after hours	Day +1 -24.81% 2024-12-16 Day +5 -27.00% 2024-12-20 Best recovery within 5 -23.84% 2024-12-18 13.8% of the drop was recovered five sessions later. Month end -30.38% on 2024-12-31
Close before and after $20.11 to $13.81 split-adjusted Session open, high, low $17.29, $17.78, $12.17 Opening gap -14.02% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 5,713,477 shares, $78,903,117 Relative volume 14.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	CADL Also on the opposite board this month on both boards	-31.12%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Candel Therapeutics Announces $80 Million Proposed Public Offering 12/12/2024 16:51 ET after hours Candel Therapeutics Announces Pricing of Public Offering 12/12/2024	Day +1 -37.19% 2024-12-16 Day +5 -10.71% 2024-12-20 Best recovery within 5 +1.63% 2024-12-19 65.6% of the drop was recovered five sessions later. Month end -11.43% on 2024-12-31
Close before and after $9.80 to $6.75 split-adjusted Session open, high, low $6.85, $7.14, $6.20 Opening gap -30.10% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 18,711,236 shares, $126,300,843 Relative volume 31.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	CNEY under $25M today Also on the opposite board this month on both boards	-31.00%	2024-12-05 against the close of 2024-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	CNEY Entered into Warrant Inducement Agreements with Certain Holders 12/05/2024 08:45 ET premarket	Day +1 -31.06% 2024-12-06 Day +5 -33.43% 2024-12-12 Best recovery within 5 -27.01% 2024-12-09 Five sessions later the drop was 7.8% bigger, at -33.43%. Month end -38.31% on 2024-12-31
Close before and after $12.77 to $8.81 split-adjusted Session open, high, low $11.25, $11.78, $8.50 Opening gap -11.87% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 286,329 shares, $2,521,843 Relative volume 33.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	ENZ	-30.69%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update 12/16/2024 16:17 ET after hours	Day +1 -30.19% 2024-12-18 Day +5 -28.03% 2024-12-24 Best recovery within 5 -24.49% 2024-12-20 8.7% of the drop was recovered five sessions later. Month end -29.28% on 2024-12-31
Close before and after $1.01 to $0.7000 as traded Session open, high, low $0.9300, $0.9300, $0.6823 Opening gap -7.92% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 1,735,162 shares, $1,214,613 Relative volume 16.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	PHIO under $25M today	-30.68%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762 12/19/2024 07:45 ET premarket Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 12/19/2024	Day +1 -29.88% 2024-12-20 Day +5 -23.11% 2024-12-27 Best recovery within 5 -11.16% 2024-12-23 24.7% of the drop was recovered five sessions later. Month end -28.29% on 2024-12-31
Close before and after $2.51 to $1.74 split-adjusted Session open, high, low $2.82, $3.00, $1.53 Opening gap +12.35% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 6,017,551 shares, $10,470,539 Relative volume 181.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
58	RDZN More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-30.61%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Roadzen and Mizuho Agree To Extend Senior Debt Maturity by Full year to December 31, 2025 12/12/2024 09:55 ET intraday	Day +1 -27.35% 2024-12-13 Day +5 -16.33% 2024-12-19 Best recovery within 5 -16.33% 2024-12-19 46.7% of the drop was recovered five sessions later. Month end -11.02% on 2024-12-31
Close before and after $2.45 to $1.70 split-adjusted Session open, high, low $2.36, $2.38, $1.70 Opening gap -3.67% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 740,880 shares, $1,259,496 Relative volume 5.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	RDZN More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-29.78%	2024-12-16 against the close of 2024-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Roadzen Inc. Announces Pricing of Public Offering 12/15/2024 22:30 ET after hours	Day +1 -23.60% 2024-12-17 Day +5 +38.20% 2024-12-23 Best recovery within 5 +38.20% 2024-12-20 It recovered the whole drop and closed 38.20% above the pre-news price. Month end +22.47% on 2024-12-31
Close before and after $1.78 to $1.25 split-adjusted Session open, high, low $1.22, $1.34, $1.18 Opening gap -31.46% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 2,497,495 shares, $3,121,869 Relative volume 12.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
60	XBIT	-29.47%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	XBiotech Pauses Rheumatology program 12/23/2024 09:00 ET premarket	Day +1 -28.53% 2024-12-24 Day +5 -38.09% 2024-12-31 Best recovery within 5 -28.53% 2024-12-24 Five sessions later the drop was 29.3% bigger, at -38.09%. Month end -38.09% on 2024-12-31
Close before and after $6.38 to $4.50 split-adjusted Session open, high, low $5.07, $5.11, $3.51 Opening gap -20.53% Close inside the session range 0.62 of the range, where 1.00 is the high Session volume 473,368 shares, $2,130,156 Relative volume 7.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
61	PLRZ under $25M today Also on the opposite board this month release reads positive on both boards	-29.18%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change Release reads positive, stock fell 29.18%	Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs 12/19/2024 07:22 ET premarket	Day +1 -52.28% 2024-12-20 Day +5 -50.15% 2024-12-27 Best recovery within 5 -36.78% 2024-12-24 Five sessions later the drop was 71.9% bigger, at -50.15%. Month end -34.04% on 2024-12-31
Close before and after $4,935.00 to $3,495.00 split-adjusted Session open, high, low $3,690.00, $4,590.00, $2,392.50 Opening gap -25.23% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 2,391 shares, $8,356,545 Relative volume 51.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	CMCT under $25M today	-28.53%	2024-12-09 against the close of 2024-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CMCT Closes $92.2 Million Loan for Sheraton Grand Sacramento Hotel 12/09/2024 08:00 ET premarket	Day +1 -22.78% 2024-12-10 Day +5 -37.64% 2024-12-16 Best recovery within 5 -22.78% 2024-12-10 Five sessions later the drop was 31.9% bigger, at -37.64%. Month end -21.52% on 2024-12-31
Close before and after $7,167.50 to $5,122.50 split-adjusted Session open, high, low $6,855.00, $7,268.75, $4,505.00 Opening gap -4.36% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 276 shares, $1,413,810 Relative volume 9.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
63	CTM	-28.46%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Castellum, Inc. Announces Pricing of $3.6 Million Registered Direct Offering 12/23/2024 06:50 ET premarket Castellum, Inc. Wins OASIS+ Unrestricted IDIQ Contract 12/23/2024	Day +1 -3.25% 2024-12-24 Day +5 +233.61% 2024-12-31 Best recovery within 5 +330.36% 2024-12-30 It recovered the whole drop and closed 233.61% above the pre-news price. Month end +233.61% on 2024-12-31
Close before and after $0.5995 to $0.4289 split-adjusted Session open, high, low $0.4300, $0.4400, $0.3927 Opening gap -28.27% Close inside the session range 0.77 of the range, where 1.00 is the high Session volume 12,483,618 shares, $5,354,224 Relative volume 10.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
64	TCRX	-28.23%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition 12/09/2024 17:45 ET after hours	Day +1 -33.62% 2024-12-11 Day +5 -35.99% 2024-12-17 Best recovery within 5 -33.62% 2024-12-11 Five sessions later the drop was 27.5% bigger, at -35.99%. Month end -34.48% on 2024-12-31
Close before and after $4.64 to $3.33 split-adjusted Session open, high, low $4.71, $4.71, $3.20 Opening gap +1.51% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 1,947,543 shares, $6,485,318 Relative volume 9.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	LDTC under $25M today Also on the opposite board this month on both boards	-27.66%	2024-12-18 against the close of 2024-12-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	LeddarTech Reports FY24 Results 12/18/2024 07:30 ET premarket	Day +1 -30.50% 2024-12-19 Day +5 -15.60% 2024-12-26 Best recovery within 5 -15.60% 2024-12-26 43.6% of the drop was recovered five sessions later. Month end +6.38% on 2024-12-31
Close before and after $1.41 to $1.02 as traded Session open, high, low $1.26, $1.33, $0.9200 Opening gap -10.99% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 5,310,170 shares, $5,416,373 Relative volume 18.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	GXAI under $25M today More than one ranked move this month Also on the opposite board this month release reads positive 2+ ranked moves on both boards	-27.02%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 27.02%	Gaxos Labs Expands Capabilities with Recraft AI Integration 12/12/2024 07:30 ET premarket	Day +1 -31.16% 2024-12-13 Day +5 -49.31% 2024-12-19 Best recovery within 5 -28.21% 2024-12-17 Five sessions later the drop was 82.5% bigger, at -49.31%. Month end -49.31% on 2024-12-31
Close before and after $5.07 to $3.70 split-adjusted Session open, high, low $4.99, $5.10, $3.70 Opening gap -1.58% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 4,315,658 shares, $15,967,935 Relative volume 11.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	PRZO under $25M today release reads positive	-26.55%	2024-12-03 against the close of 2024-12-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 26.55%	ParaZero Successfully Delivers Custom Drone Safety System to one of the Largest Global Automotive Manufacturers 12/03/2024 07:05 ET premarket	Day +1 -9.60% 2024-12-04 Day +5 -23.73% 2024-12-10 Best recovery within 5 +4.52% 2024-12-06 10.6% of the drop was recovered five sessions later. Month end +14.69% on 2024-12-31
Close before and after $1.77 to $1.30 split-adjusted Session open, high, low $1.65, $1.68, $1.30 Opening gap -6.78% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 9,810,226 shares, $12,753,294 Relative volume 93.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
68	LICN under $25M today	-25.96%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Lichen China Limited Announces $2.70 Million Registered Direct Offering 12/12/2024 14:30 ET intraday	Day +1 -30.50% 2024-12-13 Day +5 -38.21% 2024-12-19 Best recovery within 5 -30.50% 2024-12-13 Five sessions later the drop was 47.2% bigger, at -38.21%. Month end -32.88% on 2024-12-31
Close before and after $52.92 to $39.18 split-adjusted Session open, high, low $51.28, $83.00, $38.40 Opening gap -3.10% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 405,558 shares, $15,889,762 Relative volume 28.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	EVGO	-25.95%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	EVgo Inc. Announces Secondary Offering of Class A Common Stock 12/16/2024 16:10 ET after hours EVgo Inc. Announces Pricing of Secondary Offering of Class A Common Stock 12/17/2024	Day +1 -29.43% 2024-12-18 Day +5 -32.44% 2024-12-24 Best recovery within 5 -29.43% 2024-12-18 Five sessions later the drop was 25.0% bigger, at -32.44%. Month end -35.92% on 2024-12-31
Close before and after $6.32 to $4.68 split-adjusted Session open, high, low $4.89, $4.94, $4.35 Opening gap -22.63% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 46,020,163 shares, $215,374,363 Relative volume 9.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	LWLG release reads positive	-25.85%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change Release reads positive, stock fell 25.85%	Lightwave Logic to Focus on Execution of its Strategic Plan Under Refreshed Leadership Team; Appoints Yves LeMaitre as CEO and Thomas E. Zelibor as President 12/11/2024 08:31 ET premarket	Day +1 -32.83% 2024-12-12 Day +5 -27.17% 2024-12-18 Best recovery within 5 -16.23% 2024-12-16 Five sessions later the drop was 5.1% bigger, at -27.17%. Month end -20.75% on 2024-12-31
Close before and after $2.65 to $1.97 split-adjusted Session open, high, low $2.62, $2.71, $1.76 Opening gap -1.13% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 4,401,424 shares, $8,648,798 Relative volume 6.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
71	RTC under $25M today	-25.63%	2024-12-16 against the close of 2024-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Baijiayun was honored with the title of "Exclusive Member Unit" by the Beijing Educational Informationization Industry Alliance. 12/14/2024 06:30 ET premarket	Day +1 -28.33% 2024-12-17 Day +5 -31.25% 2024-12-23 Best recovery within 5 -28.33% 2024-12-17 Five sessions later the drop was 21.9% bigger, at -31.25%. Month end -24.79% on 2024-12-31
Close before and after $4.80 to $3.57 as traded Session open, high, low $4.70, $4.70, $3.57 Opening gap -2.08% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 32,662 shares, $116,603 Relative volume 1.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
72	TZUP	-25.21%	2024-12-05 against the close of 2024-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Thumzup Plans Integration of Proprietary Advertising Platform with TikTok to Significantly Expand Potential Social Media Market Reach 12/05/2024 08:18 ET premarket	Day +1 -18.57% 2024-12-06 Day +5 -39.97% 2024-12-12 Best recovery within 5 -18.57% 2024-12-06 Five sessions later the drop was 58.5% bigger, at -39.97%. Month end -43.12% on 2024-12-31
Close before and after $6.03 to $4.51 as traded Session open, high, low $6.08, $6.14, $4.33 Opening gap +0.83% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 775,144 shares, $3,495,899 Relative volume 6.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	PBM under $25M today	-25.16%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Psyence Biomedical Regains Full Compliance with All Nasdaq Continued Listing Requirements 12/23/2024 07:30 ET premarket Psyence Biomed Announces $2.0 Million Private Placement 12/23/2024	Day +1 -23.58% 2024-12-24 Day +5 -33.65% 2024-12-31 Best recovery within 5 -23.58% 2024-12-24 Five sessions later the drop was 33.7% bigger, at -33.65%. Month end -33.65% on 2024-12-31
Close before and after $158.40 to $118.55 split-adjusted Session open, high, low $128.52, $132.00, $104.26 Opening gap -18.87% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 32,138 shares, $3,810,082 Relative volume 5.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
74	GOEV under $25M today	-25.16%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Canoo Announces Furloughs and Factory Idle as it Focuses on Finalizing Securing Capital 12/18/2024 16:26 ET after hours	Day +1 -32.06% 2024-12-20 Day +5 -38.89% 2024-12-27 Best recovery within 5 -32.06% 2024-12-20 Five sessions later the drop was 54.6% bigger, at -38.89%. Month end -44.05% on 2024-12-31
Close before and after $2.52 to $1.89 as traded Session open, high, low $2.56, $2.56, $1.68 Opening gap +1.59% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 5,764,625 shares, $10,872,083 Relative volume 16.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	CURV	-25.11%	2024-12-04 against the close of 2024-12-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Torrid Reports Third Quarter Fiscal 2024 Results 12/03/2024 16:05 ET after hours	Day +1 -20.52% 2024-12-05 Day +5 -9.61% 2024-12-11 Best recovery within 5 -9.17% 2024-12-06 61.7% of the drop was recovered five sessions later. Month end +14.19% on 2024-12-31
Close before and after $4.58 to $3.43 split-adjusted Session open, high, low $3.31, $3.48, $3.00 Opening gap -27.73% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 3,179,599 shares, $10,906,025 Relative volume 8.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	STRW	-24.32%	2024-12-05 against the close of 2024-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Strawberry Fields Reit, Inc. Announces Pricing of Public Offering of Common Stock 12/05/2024 09:57 ET intraday	Day +1 -20.85% 2024-12-06 Day +5 -16.51% 2024-12-12 Best recovery within 5 -16.51% 2024-12-12 32.1% of the drop was recovered five sessions later. Month end -15.14% on 2024-12-31
Close before and after $12.42 to $9.40 split-adjusted Session open, high, low $10.50, $10.84, $9.40 Opening gap -15.46% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 1,532,351 shares, $14,404,099 Relative volume 77.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	AMPG Also on the opposite board this month on both boards	-24.18%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	AmpliTech Group Announces Pricing of $3.1 Million Registered Direct Offering 12/17/2024 09:15 ET premarket	Day +1 -18.68% 2024-12-18 Day +5 +47.99% 2024-12-24 Best recovery within 5 +47.99% 2024-12-24 It recovered the whole drop and closed 47.99% above the pre-news price. Month end +88.28% on 2024-12-31
Close before and after $2.73 to $2.07 split-adjusted Session open, high, low $2.40, $2.44, $1.98 Opening gap -12.09% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 6,125,676 shares, $12,680,149 Relative volume 21.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
78	PLCE	-24.15%	2024-12-03 against the close of 2024-12-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	The Children’s Place Reports Third Quarter 2024 Results 12/03/2024 08:00 ET premarket	Day +1 -27.83% 2024-12-04 Day +5 -12.45% 2024-12-10 Best recovery within 5 -12.45% 2024-12-10 48.4% of the drop was recovered five sessions later. Month end -35.23% on 2024-12-31
Close before and after $16.15 to $12.25 split-adjusted Session open, high, low $13.53, $13.60, $12.01 Opening gap -16.22% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 1,391,557 shares, $17,046,573 Relative volume 5.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	ATNF	-24.03%	2024-12-27 against the close of 2024-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules 12/27/2024 09:00 ET premarket	Day +1 -31.45% 2024-12-30 Day +5 -44.17% 2025-01-06 Best recovery within 5 -31.45% 2024-12-30 Five sessions later the drop was 83.8% bigger, at -44.17%. Month end -35.69% on 2024-12-31 This month ended before the fifth session after the move.
Close before and after $2.83 to $2.15 as traded Session open, high, low $2.55, $2.61, $2.10 Opening gap -9.89% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 591,618 shares, $1,271,979 Relative volume 10.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	CMTG	-23.89%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	Claros Mortgage Trust, Inc. Pauses Common Stock Dividend 12/16/2024 17:58 ET after hours	Day +1 -31.21% 2024-12-18 Day +5 -32.32% 2024-12-24 Best recovery within 5 -31.21% 2024-12-18 Five sessions later the drop was 35.3% bigger, at -32.32%. Month end -28.03% on 2024-12-31
Close before and after $6.28 to $4.78 split-adjusted Session open, high, low $6.17, $6.17, $4.71 Opening gap -1.75% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 945,052 shares, $4,517,349 Relative volume 3.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	LVTX	-23.82%	2024-12-10 against the close of 2024-12-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027 12/10/2024 07:30 ET premarket	Day +1 -36.65% 2024-12-11 Day +5 -45.55% 2024-12-17 Best recovery within 5 -36.65% 2024-12-11 Five sessions later the drop was 91.2% bigger, at -45.55%. Month end -50.21% on 2024-12-31
Close before and after $1.91 to $1.46 as traded Session open, high, low $1.92, $1.92, $1.45 Opening gap +0.52% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 561,928 shares, $817,605 Relative volume 14.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	EDIT	-23.81%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years 12/12/2024 16:00 ET after hours	Day +1 -21.69% 2024-12-16 Day +5 -30.69% 2024-12-20 Best recovery within 5 -19.58% 2024-12-17 Five sessions later the drop was 28.9% bigger, at -30.69%. Month end -32.80% on 2024-12-31
Close before and after $1.89 to $1.44 split-adjusted Session open, high, low $1.75, $1.77, $1.41 Opening gap -7.41% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 10,559,555 shares, $15,205,759 Relative volume 4.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	AEYE	-23.78%	2024-12-05 against the close of 2024-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	AudioEye Announces Launch of Secondary Offering of Common Stock by Selling Stockholders 12/04/2024 16:01 ET after hours AudioEye Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders 12/05/2024	Day +1 -18.26% 2024-12-06 Day +5 -32.58% 2024-12-12 Best recovery within 5 -18.26% 2024-12-06 Five sessions later the drop was 37.0% bigger, at -32.58%. Month end -44.00% on 2024-12-31
Close before and after $27.16 to $20.70 split-adjusted Session open, high, low $22.98, $23.12, $20.25 Opening gap -15.39% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 1,867,435 shares, $38,655,905 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	OPTX Also on the opposite board this month on both boards	-23.62%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Matt Carey to Lead Business Development and Delivery at Syntec Optics (Nasdaq: OPTX) 12/19/2024 08:29 ET premarket	Day +1 +37.80% 2024-12-20 Day +5 +31.50% 2024-12-27 Best recovery within 5 +37.80% 2024-12-20 It recovered the whole drop and closed 31.50% above the pre-news price. Month end -0.79% on 2024-12-31
Close before and after $2.54 to $1.94 split-adjusted Session open, high, low $2.54, $2.68, $1.89 Opening gap 0.00% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 1,519,495 shares, $2,947,820 Relative volume 9.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	DNMR under $25M today More than one ranked move this month 2+ ranked moves	-23.40%	2024-12-18 against the close of 2024-12-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Danimer Scientific Takes Action to Strengthen Capital Structure 12/17/2024 16:15 ET after hours	Day +1 -32.45% 2024-12-19 Day +5 +15.96% 2024-12-26 Best recovery within 5 +15.96% 2024-12-26 It recovered the whole drop and closed 15.96% above the pre-news price. Month end -44.15% on 2024-12-31
Close before and after $3.76 to $2.88 as traded Session open, high, low $3.81, $3.93, $2.83 Opening gap +1.33% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 204,616 shares, $589,294 Relative volume 3.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	AQB under $25M today	-23.22%	2024-12-11 against the close of 2024-12-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	AquaBounty Announces Plans to Cease Fish Farming Operations 12/11/2024 08:00 ET premarket	Day +1 -34.10% 2024-12-12 Day +5 -40.12% 2024-12-18 Best recovery within 5 -34.10% 2024-12-12 Five sessions later the drop was 72.8% bigger, at -40.12%. Month end -32.55% on 2024-12-31
Close before and after $0.9287 to $0.7131 split-adjusted Session open, high, low $0.8997, $0.9000, $0.5700 Opening gap -3.12% Close inside the session range 0.43 of the range, where 1.00 is the high Session volume 953,591 shares, $680,006 Relative volume 34.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	BTCT More than one ranked move this month 2+ ranked moves	-23.07%	2024-12-12 against the close of 2024-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	BTC Digital Ltd. Announces Exercise of Over-Allotment Option in Public Offering 12/12/2024 10:19 ET intraday	Day +1 -22.95% 2024-12-13 Day +5 -47.22% 2024-12-19 Best recovery within 5 -22.95% 2024-12-13 Five sessions later the drop was 104.7% bigger, at -47.22%. Month end -42.27% on 2024-12-31
Close before and after $8.28 to $6.37 split-adjusted Session open, high, low $8.11, $8.14, $6.12 Opening gap -2.05% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 1,149,010 shares, $7,319,194 Relative volume 0.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	IIPR	-22.74%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Innovative Industrial Properties Reports Default by PharmaCann on All Leases 12/20/2024 06:55 ET premarket	Day +1 -26.11% 2024-12-23 Day +5 -29.40% 2024-12-30 Best recovery within 5 -25.83% 2024-12-26 Five sessions later the drop was 29.3% bigger, at -29.40%. Month end -30.10% on 2024-12-31
Close before and after $95.34 to $73.66 split-adjusted Session open, high, low $74.00, $77.95, $70.88 Opening gap -22.38% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 3,148,660 shares, $231,930,296 Relative volume 17.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
89	GXAI under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-22.59%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 12/19/2024 08:00 ET premarket	Day +1 -28.01% 2024-12-20 Day +5 -10.54% 2024-12-27 Best recovery within 5 +7.83% 2024-12-26 53.3% of the drop was recovered five sessions later. Month end -22.59% on 2024-12-31
Close before and after $3.32 to $2.57 split-adjusted Session open, high, low $3.06, $3.15, $2.46 Opening gap -7.83% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 2,457,967 shares, $6,316,975 Relative volume 4.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	CMCM	-22.06%	2024-12-17 against the close of 2024-12-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Cheetah Mobile Announces Third Quarter 2024 Unaudited Consolidated Financial Results 12/17/2024 03:30 ET premarket	Day +1 -25.49% 2024-12-18 Day +5 -23.04% 2024-12-24 Best recovery within 5 -22.06% 2024-12-23 Five sessions later the drop was 4.4% bigger, at -23.04%. Month end -24.84% on 2024-12-31
Close before and after $6.12 to $4.77 split-adjusted Session open, high, low $5.97, $6.05, $4.66 Opening gap -2.45% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 209,543 shares, $999,520 Relative volume 4.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	BASE	-21.92%	2024-12-04 against the close of 2024-12-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Couchbase Announces Third Quarter Fiscal 2025 Financial Results 12/03/2024 16:05 ET after hours	Day +1 -22.02% 2024-12-05 Day +5 -23.91% 2024-12-11 Best recovery within 5 -22.02% 2024-12-05 Five sessions later the drop was 9.1% bigger, at -23.91%. Month end -26.18% on 2024-12-31
Close before and after $21.12 to $16.49 as traded Session open, high, low $18.17, $18.27, $16.00 Opening gap -13.97% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 2,389,487 shares, $39,402,641 Relative volume 7.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	XELB under $25M today	-21.91%	2024-12-20 against the close of 2024-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Xcel Brands to Host Third Quarter 2024 Earnings Call on December 23, 2024 12/19/2024 17:00 ET after hours	Day +1 -33.62% 2024-12-23 Day +5 +1.91% 2024-12-30 Best recovery within 5 +1.91% 2024-12-30 It recovered the whole drop and closed 1.91% above the pre-news price. Month end +0.55% on 2024-12-31
Close before and after $5.12 to $4.00 split-adjusted Session open, high, low $5.10, $5.15, $3.55 Opening gap -0.43% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 35,734 shares, $142,936 Relative volume 12.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	UAVS	-21.84%	2024-12-19 against the close of 2024-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	AgEagle Aerial Systems Announces Milestone Order of 60 RedEdge-P Multispectral Sensors 12/19/2024 08:00 ET premarket	Day +1 -30.26% 2024-12-20 Day +5 -29.86% 2024-12-27 Best recovery within 5 -21.84% 2024-12-26 Five sessions later the drop was 36.7% bigger, at -29.86%. Month end -30.46% on 2024-12-31
Close before and after $4.99 to $3.90 split-adjusted Session open, high, low $5.53, $5.56, $3.77 Opening gap +10.82% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 2,313,102 shares, $9,021,098 Relative volume 1.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	RENT	-21.84%	2024-12-09 against the close of 2024-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Rent the Runway, Inc. Announces Third Quarter 2024 Results 12/09/2024 08:01 ET premarket Rent the Runway and Dallas Cowboys Cheerleaders Team Up for Empowering Partnership 12/09/2024	Day +1 -25.51% 2024-12-10 Day +5 -33.39% 2024-12-16 Best recovery within 5 -25.51% 2024-12-10 Five sessions later the drop was 52.9% bigger, at -33.39%. Month end -33.70% on 2024-12-31
Close before and after $12.82 to $10.02 split-adjusted Session open, high, low $12.69, $12.69, $9.53 Opening gap -1.01% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 591,970 shares, $5,931,539 Relative volume 11.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
95	LRMR	-21.72%	2024-12-16 against the close of 2024-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Larimar Therapeutics Announces Positive Initial Data from Ongoing Long-term Open Label Extension Study & Progress Across Nomlabofusp Program for Friedreich’s Ataxia 12/16/2024 07:00 ET premarket	Day +1 -29.98% 2024-12-17 Day +5 -35.82% 2024-12-23 Best recovery within 5 -29.98% 2024-12-17 Five sessions later the drop was 64.9% bigger, at -35.82%. Month end -37.28% on 2024-12-31
Close before and after $6.17 to $4.83 split-adjusted Session open, high, low $3.95, $5.17, $3.01 Opening gap -35.98% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 6,096,841 shares, $29,447,742 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
96	WHLM under $25M today	-21.55%	2024-12-23 against the close of 2024-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Wilhelmina International, Inc. Announces Voluntary Delisting from the Nasdaq Capital Market 12/20/2024 20:40 ET after hours	Day +1 -17.92% 2024-12-24 Day +5 -14.04% 2024-12-31 Best recovery within 5 -14.04% 2024-12-31 34.8% of the drop was recovered five sessions later. Month end -14.04% on 2024-12-31
Close before and after $4,130.00 to $3,240.00 as traded Session open, high, low $3,420.00, $3,525.00, $3,080.00 Opening gap -17.19% Close inside the session range 0.36 of the range, where 1.00 is the high Session volume 113 shares, $366,120 Relative volume 37.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
97	LAES Also on the opposite board this month on both boards	-21.48%	2024-12-18 against the close of 2024-12-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	SEALSQ Announces Pricing of $25.0 Million Registered Direct Offering 12/17/2024 20:00 ET after hours	Day +1 -32.55% 2024-12-19 Day +5 +193.96% 2024-12-26 Best recovery within 5 +193.96% 2024-12-26 It recovered the whole drop and closed 193.96% above the pre-news price. Month end +106.38% on 2024-12-31
Close before and after $2.98 to $2.34 split-adjusted Session open, high, low $2.80, $3.05, $2.16 Opening gap -6.04% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 73,973,314 shares, $173,097,555 Relative volume 20.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	PRTG under $25M today Also on the opposite board this month on both boards	-21.47%	2024-12-13 against the close of 2024-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter 12/12/2024 16:15 ET after hours	Day +1 -14.92% 2024-12-16 Day +5 +56.02% 2024-12-20 Best recovery within 5 +136.65% 2024-12-17 It recovered the whole drop and closed 56.02% above the pre-news price. Month end +35.34% on 2024-12-31
Close before and after $3.82 to $3.00 as traded Session open, high, low $3.47, $3.55, $2.95 Opening gap -9.16% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 35,345 shares, $106,035 Relative volume 1.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	AGIO	-21.09%	2024-12-09 against the close of 2024-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat 12/08/2024 12:40 ET intraday	Day +1 -25.34% 2024-12-10 Day +5 -30.74% 2024-12-16 Best recovery within 5 -25.34% 2024-12-10 Five sessions later the drop was 45.8% bigger, at -30.74%. Month end -46.69% on 2024-12-31
Close before and after $61.64 to $48.64 split-adjusted Session open, high, low $56.11, $57.33, $44.62 Opening gap -8.97% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 3,080,677 shares, $149,844,129 Relative volume 5.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
100	UIS	-21.08%	2024-12-06 against the close of 2024-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Unisys Appoints Michael M. Thomson as Chief Executive Officer 12/05/2024 16:30 ET after hours	Day +1 -18.27% 2024-12-09 Day +5 -22.31% 2024-12-13 Best recovery within 5 -18.27% 2024-12-09 Five sessions later the drop was 5.8% bigger, at -22.31%. Month end -29.04% on 2024-12-31
Close before and after $8.92 to $7.04 split-adjusted Session open, high, low $8.65, $8.65, $6.82 Opening gap -3.03% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 2,357,905 shares, $16,599,651 Relative volume 4.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 181 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2024, the median decliner was 5.8% deeper below its pre-news close five sessions later; the largest catalyst group was Offering / Dilution, 30 of the 100 events, at a median of -32.2%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still below the pre-news close at day +5
Offering / Dilution	30	30.0%	-32.2%	-37.2%	80.0% of 30
Other Announcement	29	29.0%	-30.6%	-36.7% of 28	85.7% of 28
Clinical Trial Results	16	16.0%	-42.9%	-43.7%	100.0% of 16
Earnings	13	13.0%	-25.1%	-28.0%	92.3% of 13
FDA & Regulatory	3	3.0%	Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 9 events: Uplisting / Compliance, Leadership Change, M&A / Acquisition, Contract / Partnership, Buyback / Dividend.

How much of the drop held

Horizon	Still below the pre-news close close to close	Median change since the measured close as a share of the drop
Day +1	97.0% of 100	2.7% deeper below baseline, of 100
Day +5	88.9% of 99	5.8% deeper below baseline, of 99
Month end	83.9% of 93	3.4% deeper below baseline, of 93
Month end falls before day +5 for 7 of these 93 events, so this row is not a later horizon than the one above it. 93 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2024

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Largest drop
LITM	2Offering / Dilution	-63.14%
DNMR	2Other Announcement, Offering / Dilution	-49.15%
TNXP	2FDA & Regulatory	-37.00%
BTCT	2Offering / Dilution	-32.95%
RDZN	2Other Announcement, Offering / Dilution	-30.61%
GXAI	2Other Announcement, Offering / Dilution	-27.02%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Largest drop
AMIX	2024-11, 2024-10	-53.55%
KXIN	2024-11, 2024-10	-40.19%
LILM	2024-11, 2024-10	-36.97%
PGY	2024-11, 2024-09	-35.58%
BYU	2024-10, 2024-09	-73.02%
APDN	2024-10, 2024-09	-40.56%
LASE	2024-10, 2024-09	-38.81%
PBMthis month too	2024-10, 2024-09	-34.99%
BIVI	2024-10, 2024-09	-57.86%
HSDT	2024-10, 2024-09	-22.05%
STEM	2024-10, 2024-09	-21.60%
UAVSthis month too	2024-10, 2024-09	-64.57%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

1 event has too little trading history for a relative volume, and is not in the tiers above.

Industry

26 other industries, 30 events

Industry not known: 19.0%

When the release and the price disagreed

12 events on this board carry the flag.

Flagged events sat 13.7 percentage points below the rest of the board five sessions later.

Median at day +5, flagged: -47.3%
Median at day +5, not flagged: -33.6%

Against November 2024

100 events in the comparable window.

November 2024 median -34.0%, selected from the 9,889 events in that month's eligible pool

December 2024 median -31.9%, 2.1 points shallower than November 2024. December 2024's median is taken over the 100 ranked rows, selected from the 6,647 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.